Lv1
28 积分 2023-06-13 加入
Expanding Horizons for Treatment of Early-Stage Lung Cancer
5小时前
待确认
New promises and challenges in the treatment of advanced non-small-cell lung cancer
6小时前
已完结
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
5天前
已完结
TIGIT regulates CD4+ T cell immunity against polymicrobial sepsis
18天前
已完结
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non-Small-Cell Lung Cancer to Gefitinib
1个月前
已完结
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
1个月前
已完结
Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)
1个月前
已完结
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
1个月前
已完结
ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation
1个月前
已完结
Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis
1个月前
已完结
皖公网安备34019202002308
